Advancements in genetic testing technology and increased awareness and early detection of genetic disorders are some of the leading factors driving carrier screening market growth. Carrier screening Carrier screening is a diagnostic test used to identify individuals who carry genetic mutations for inherited diseases.
The market has expanded significantly due to rising awareness, progress in genomics, and the increasing demand for personalized medicine. In line with the latest carrier screening market trends key players are actively investing in research and development to enhance the accuracy, efficiency, and accessibility of genetic testing.
They are leveraging advanced technologies such as next-generation sequencing (NGS) and artificial intelligence (AI) to improve the detection of genetic mutations and provide more comprehensive screening results. These innovations enable faster and more cost-effective testing, making carrier screening more widely available to individuals and healthcare providers.
Carrier screening is a genetic test that detects if a person is carrying a gene mutation that they may pass onto their offspring, leading to genetic diseases. It is typically advised for couples who intend to have a family and particularly those with a history of genetic diseases in the family or who originate from an ethnic group with an increased risk for certain diseases.
This test can identify carriers of recessive disorders like cystic fibrosis, sickle cell anemia, and Tay-Sachs disease. If both parents are carriers of the same genetic disorder, they are more likely to pass it on to their child. Carrier screening can be useful in providing information for family planning, enabling couples to discuss reproductive choices and make informed decisions about their future.
| Attribute | Detail |
|---|---|
| Market Drivers |
|
The global carrier screening industry has witnessed substantial growth, driven by advancements in genetic testing technologies. Innovations such as next-generation sequencing (NGS), array-based technologies, and CRISPR-based gene editing have significantly improved the accuracy, efficiency, and affordability of genetic tests.
NGS, in particular, enables the simultaneous analysis of multiple genetic variants linked to hereditary diseases, making comprehensive carrier screening more effective and accessible.
These technological advancements have also facilitated the development of personalized and detailed carrier screening tests, enhancing the detection of genetic mutations that may be passed on to offspring. As more diseases are understood at a molecular level, new tests targeting specific conditions prevalent in certain populations are emerging.
Additionally, reduced test turnaround times allow healthcare providers to deliver faster results, increasing adoption rates. With improved precision and broader screening capabilities, these innovations are fueling the global demand for carrier screening services, further propelling carrier screening market share.
Growing awareness of genetic disorders and the benefits of early detection is significantly driving the expansion of the carrier screening market. As individuals gain a better understanding of hereditary conditions, they are increasingly opting for carrier screening tests before or during pregnancy.
Educational campaigns, media influence, and healthcare professionals’ efforts have been instrumental in integrating genetic testing into routine reproductive care. This heightened awareness promotes proactive health decisions, helping couples assess their genetic risks and make informed choices.
Carrier screening enables the early detection of conditions like cystic fibrosis, sickle cell anemia, and Tay-Sachs disease, empowering individuals with crucial reproductive information. The rise of personalized medicine has further deepened the understanding of genetic health, making testing more mainstream.
Social media and advocacy groups also play a vital role in spreading awareness, especially in communities where inherited disorders are more common. As education and access to genetic testing improve, the demand for carrier screening continues to rise, reinforcing its importance in preventive healthcare and boosting carrier screening market value.
The global carrier screening market is primarily driven by the widespread adoption of expanded carrier screening (ECS), which enables the testing of a broad range of genetic conditions in individuals. Unlike traditional screening methods that focus on specific populations or family history, ECS offers a more comprehensive approach by testing for over 100 genetic conditions, including rare and recessive diseases.
This allows for the early detection of genetic mutations that may not be apparent from a person's ancestry or medical background, increasing the chances of early intervention.
Companies such as Invitae provide extensive carrier screening panels that test for more than 200 conditions, giving individuals a clearer understanding of their genetic risks. Even those with no known hereditary conditions often opt for ECS to uncover potential risks for diseases like cystic fibrosis, Tay-Sachs disease, or fragile X syndrome, helping them make informed reproductive decisions.
The blood sample type dominates the global carrier screening market due to its high reliability, accuracy, and DNA yield, which are crucial for effective genetic testing. Compared to other sample types like saliva or cheek swabs, blood samples contain a higher concentration of high-quality DNA, leading to more precise and reproducible results.
This is especially important for ECS, which relies on advanced sequencing technologies such as next-generation sequencing (NGS) to provide in-depth genetic insights. For instance, LabCorp, a leading genetic testing provider, utilizes blood samples for its expanded carrier screening tests, allowing for the detection of over 200 genetic disorders.
Blood-based testing is considered the gold standard for carrier screening, ensuring accuracy, minimizing errors, and enhancing the reliability of results. The widespread use of blood samples has strengthened the market's growth, particularly in regions with advanced healthcare systems that prioritize precision medicine and genetic disease prevention.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
According to the latest carrier screening market analysis, North America held the largest share in 2024. This dominance is attributed to several factors, including a well-developed medical infrastructure, high awareness of genetic diseases, and significant investment in genetic testing technologies. The United States has been at the forefront of next-generation sequencing (NGS) and other advanced genetic testing methods, driving the expansion of carrier screening.
Additionally, North American healthcare policies actively promote genetic testing as a standard component of medical care, particularly for prospective parents and pregnant women undergoing prenatal screening. The region's increasing focus on personalized medicine and preventive healthcare has further fueled the demand for carrier screening, solidifying its leadership in the global market.
For instance, leading U.S. healthcare providers and testing companies, including Invitae and GeneDx, provide large carrier screening panels, encompassing testing for a broad range of genetic disorders. The services are well accepted and entrenched in clinical practice, which facilitates the region's leadership in the market.
With the high adoption rates of genetic testing and ongoing coverage by healthcare systems, North America will continue to be the largest market for carrier screening, with a large proportion of the overall market in 2024.
Key players operating in the carrier screening industry are investing through innovation, technological advancements, and strategic partnerships. Their efforts are focused on improving test accuracy, expanding product offerings, and strengthening their market presence to maintain a competitive edge in the evolving healthcare industry.
Myriad Genetics, Inc., Cepheid, Illumina, Thermo Fisher Scientific Inc., F.Hoffmann-La Roche Ltd, LabCorp, Otogenetics, MedGenome, GeneTech, Centogene N.V., Fulgent Genetics, OPKO Health Inc., Quest Diagnostics Incorporated, Natera Inc. and others are some of the leading key players.
Each of these players has been profiled in the carrier screening market research report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
| Attribute | Detail |
|---|---|
| Size in 2024 | US$ 1.7 Bn |
| Forecast Value in 2035 | US$ 5.8 Bn |
| CAGR | 11.8% |
| Forecast Period | 2025-2035 |
| Historical Data Available for | 2020-2024 |
| Quantitative Units | US$ Bn |
| Carrier Screening Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 1.7 Bn in 2024.
The carrier screening market is projected to cross US$ 5.8 Bn by the end of 2035.
Advancements in genetic testing technology and increased awareness and early detection of genetic disorders.
It is anticipated to grow at a CAGR of 11.8% from 2025 to 2035.
North America is expected to account for the largest share from 2025 to 2035.
Myriad Genetics, Inc., Cepheid, Illumina, Thermo Fisher Scientific Inc., F.Hoffmann-La Roche Ltd, LabCorp., Otogenetics, MedGenome, GeneTech, Centogene N.V., Fulgent Genetics, OPKO Health Inc., Quest Diagnostics Incorporated, Natera Inc. and Others.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Carrier Screening Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Carrier Screening Market Analysis and Forecast, 2020-2035
4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
5.1. Key Industry Events
5.2. PORTER’s Five Forces Analysis
5.3. Supply Chain Analysis
5.4. PESTLE Analysis
5.5. Technological Advancements
5.6. Unmet Needs of the Market
5.7. Epidemiology of Diseases
6. Global Carrier Screening Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Type, 2020-2035
6.3.1. Expanded Carrier Screening
6.3.2. Targeted Disease Carrier Screening
6.4. Market Attractiveness Analysis, by Type
7. Global Carrier Screening Market Analysis and Forecast, by Sample Type
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Sample Type, 2020-2035
7.3.1. Blood
7.3.2. Saliva
7.3.3. Others
7.4. Market Attractiveness Analysis, by Sample Type
8. Global Carrier Screening Market Analysis and Forecast, by Technique
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Technique, 2020-2035
8.3.1. DNA Sequencing
8.3.2. Polymerase Chain Reaction
8.3.3. Microarrays
8.3.4. Others
8.4. Market Attractiveness Analysis, by Technique
9. Global Carrier Screening Market Analysis and Forecast, by Application
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by Application, 2020-2035
9.3.1. Cystic Fibrosis
9.3.2. Tay-Sachs
9.3.3. Gaucher Disease
9.3.4. Sickle Cell Disease
9.3.5. Others
9.4. Market Attractiveness Analysis, by Application
10. Global Carrier Screening Market Analysis and Forecast, by End-user
10.1. Introduction & Definition
10.2. Key Findings/Developments
10.3. Market Value Forecast, by End-user, 2020-2035
10.3.1. Hospitals & Clinics
10.3.2. Reference Laboratories
10.3.3. Others
10.4. Market Attractiveness Analysis, by End-user
11. Global Carrier Screening Market Analysis and Forecast, by Region
11.1. Key Findings
11.2. Market Value Forecast, by Region, 2020-2035
11.2.1. North America
11.2.2. Europe
11.2.3. Asia Pacific
11.2.4. Latin America
11.2.5. Middle East & Africa
11.3. Market Attractiveness Analysis, by Region
12. North America Carrier Screening Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type, 2020-2035
12.2.1. Expanded Carrier Screening
12.2.2. Targeted Disease Carrier Screening
12.3. Market Value Forecast, by Sample Type, 2020-2035
12.3.1. Blood
12.3.2. Saliva
12.3.3. Others
12.4. Market Value Forecast, by Technique, 2020-2035
12.4.1. DNA Sequencing
12.4.2. Polymerase Chain Reaction
12.4.3. Microarrays
12.4.4. Others
12.5. Market Value Forecast, by Application, 2020-2035
12.5.1. Cystic Fibrosis
12.5.2. Tay-Sachs
12.5.3. Gaucher Disease
12.5.4. Sickle Cell Disease
12.5.5. Others
12.6. Market Value Forecast, by End-user, 2020-2035
12.6.1. Hospitals & Clinics
12.6.2. Reference Laboratories
12.6.3. Others
12.7. Market Value Forecast, by Country, 2020-2035
12.7.1. U.S.
12.7.2. Canada
12.8. Market Attractiveness Analysis
12.8.1. By Type
12.8.2. By Sample Type
12.8.3. By Technique
12.8.4. By Application
12.8.5. By End-user
12.8.6. By Country
13. Europe Carrier Screening Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Type, 2020-2035
13.2.1. Expanded Carrier Screening
13.2.2. Targeted Disease Carrier Screening
13.3. Market Value Forecast, by Sample Type, 2020-2035
13.3.1. Blood
13.3.2. Saliva
13.3.3. Others
13.4. Market Value Forecast, by Technique, 2020-2035
13.4.1. DNA Sequencing
13.4.2. Polymerase Chain Reaction
13.4.3. Microarrays
13.4.4. Others
13.5. Market Value Forecast, by Application, 2020-2035
13.5.1. Cystic Fibrosis
13.5.2. Tay-Sachs
13.5.3. Gaucher Disease
13.5.4. Sickle Cell Disease
13.5.5. Others
13.6. Market Value Forecast, by End-user, 2020-2035
13.6.1. Hospitals & Clinics
13.6.2. Reference Laboratories
13.6.3. Others
13.7. Market Value Forecast, by Country/Sub-region, 2020-2035
13.7.1. Germany
13.7.2. UK
13.7.3. France
13.7.4. Italy
13.7.5. Spain
13.7.6. Rest of Europe
13.8. Market Attractiveness Analysis
13.8.1. By Type
13.8.2. By Sample Type
13.8.3. By Technique
13.8.4. By Application
13.8.5. By End-user
13.8.6. By Country/Sub-region
14. Asia Pacific Carrier Screening Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Type, 2020-2035
14.2.1. Expanded Carrier Screening
14.2.2. Targeted Disease Carrier Screening
14.3. Market Value Forecast, by Sample Type, 2020-2035
14.3.1. Blood
14.3.2. Saliva
14.3.3. Others
14.4. Market Value Forecast, by Technique, 2020-2035
14.4.1. DNA Sequencing
14.4.2. Polymerase Chain Reaction
14.4.3. Microarrays
14.4.4. Others
14.5. Market Value Forecast, by Application, 2020-2035
14.5.1. Cystic Fibrosis
14.5.2. Tay-Sachs
14.5.3. Gaucher Disease
14.5.4. Sickle Cell Disease
14.5.5. Others
14.6. Market Value Forecast, by End-user, 2020-2035
14.6.1. Hospitals & Clinics
14.6.2. Reference Laboratories
14.6.3. Others
14.7. Market Value Forecast, by Country/Sub-region, 2020-2035
14.7.1. China
14.7.2. Japan
14.7.3. India
14.7.4. Australia & New Zealand
14.7.5. Rest of Asia Pacific
14.8. Market Attractiveness Analysis
14.8.1. By Type
14.8.2. By Sample Type
14.8.3. By Technique
14.8.4. By Application
14.8.5. By End-user
14.8.6. By Country/Sub-region
15. Latin America Carrier Screening Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Type, 2020-2035
15.2.1. Expanded Carrier Screening
15.2.2. Targeted Disease Carrier Screening
15.3. Market Value Forecast, by Sample Type, 2020-2035
15.3.1. Blood
15.3.2. Saliva
15.3.3. Others
15.4. Market Value Forecast, by Technique, 2020-2035
15.4.1. DNA Sequencing
15.4.2. Polymerase Chain Reaction
15.4.3. Microarrays
15.4.4. Others
15.5. Market Value Forecast, by Application, 2020-2035
15.5.1. Cystic Fibrosis
15.5.2. Tay-Sachs
15.5.3. Gaucher Disease
15.5.4. Sickle Cell Disease
15.5.5. Others
15.6. Market Value Forecast, by End-user, 2020-2035
15.6.1. Hospitals & Clinics
15.6.2. Reference Laboratories
15.6.3. Others
15.7. Market Value Forecast, by Country/Sub-region, 2020-2035
15.7.1. Brazil
15.7.2. Mexico
15.7.3. Rest of Latin America
15.8. Market Attractiveness Analysis
15.8.1. By Type
15.8.2. By Sample Type
15.8.3. By Technique
15.8.4. By Application
15.8.5. By End-user
15.8.6. By Country/Sub-region
16. Middle East & Africa Carrier Screening Market Analysis and Forecast
16.1. Introduction
16.1.1. Key Findings
16.2. Market Value Forecast, by Type, 2020-2035
16.2.1. Expanded Carrier Screening
16.2.2. Targeted Disease Carrier Screening
16.3. Market Value Forecast, by Sample Type, 2020-2035
16.3.1. Blood
16.3.2. Saliva
16.3.3. Others
16.4. Market Value Forecast, by Technique, 2020-2035
16.4.1. DNA Sequencing
16.4.2. Polymerase Chain Reaction
16.4.3. Microarrays
16.4.4. Others
16.5. Market Value Forecast, by Application, 2020-2035
16.5.1. Cystic Fibrosis
16.5.2. Tay-Sachs
16.5.3. Gaucher Disease
16.5.4. Sickle Cell Disease
16.5.5. Others
16.6. Market Value Forecast, by End-user, 2020-2035
16.6.1. Hospitals & Clinics
16.6.2. Reference Laboratories
16.6.3. Others
16.7. Market Value Forecast, by Country/Sub-region, 2020-2035
16.7.1. GCC Countries
16.7.2. South Africa
16.7.3. Rest of Middle East & Africa
16.8. Market Attractiveness Analysis
16.8.1. By Type
16.8.2. By Sample Type
16.8.3. By Technique
16.8.4. By Application
16.8.5. By End-user
16.8.6. By Country/Sub-region
17. Competition Landscape
17.1. Market Player - Competition Matrix (By Tier and Size of companies)
17.2. Market Share Analysis, by Company (2024)
17.3. Company Profiles
17.3.1. Myriad Genetics, Inc.
17.3.1.1. Company Overview
17.3.1.2. Financial Overview
17.3.1.3. Product Portfolio
17.3.1.4. Business Strategies
17.3.1.5. Recent Developments
17.3.2. Cepheid
17.3.2.1. Company Overview
17.3.2.2. Financial Overview
17.3.2.3. Product Portfolio
17.3.2.4. Business Strategies
17.3.2.5. Recent Developments
17.3.3. Illumina
17.3.3.1. Company Overview
17.3.3.2. Financial Overview
17.3.3.3. Product Portfolio
17.3.3.4. Business Strategies
17.3.3.5. Recent Developments
17.3.4. Thermo Fisher Scientific, Inc.
17.3.4.1. Company Overview
17.3.4.2. Financial Overview
17.3.4.3. Product Portfolio
17.3.4.4. Business Strategies
17.3.4.5. Recent Developments
17.3.5. F.Hoffmann-La Roche Ltd
17.3.5.1. Company Overview
17.3.5.2. Financial Overview
17.3.5.3. Product Portfolio
17.3.5.4. Business Strategies
17.3.5.5. Recent Developments
17.3.6. LabCorp.
17.3.6.1. Company Overview
17.3.6.2. Financial Overview
17.3.6.3. Product Portfolio
17.3.6.4. Business Strategies
17.3.6.5. Recent Developments
17.3.7. Otogenetics
17.3.7.1. Company Overview
17.3.7.2. Financial Overview
17.3.7.3. Product Portfolio
17.3.7.4. Business Strategies
17.3.7.5. Recent Developments
17.3.8. MedGenome
17.3.8.1. Company Overview
17.3.8.2. Financial Overview
17.3.8.3. Product Portfolio
17.3.8.4. Business Strategies
17.3.8.5. Recent Developments
17.3.9. GeneTech
17.3.9.1. Company Overview
17.3.9.2. Financial Overview
17.3.9.3. Product Portfolio
17.3.9.4. Business Strategies
17.3.9.5. Recent Developments
17.3.10. Centogene N.V.
17.3.10.1. Company Overview
17.3.10.2. Financial Overview
17.3.10.3. Product Portfolio
17.3.10.4. Business Strategies
17.3.10.5. Recent Developments
17.3.11. Fulgent Genetics
17.3.11.1. Company Overview
17.3.11.2. Financial Overview
17.3.11.3. Product Portfolio
17.3.11.4. Business Strategies
17.3.11.5. Recent Developments
17.3.12. OPKO Health Inc.
17.3.12.1. Company Overview
17.3.12.2. Financial Overview
17.3.12.3. Product Portfolio
17.3.12.4. Business Strategies
17.3.12.5. Recent Developments
17.3.13. Quest Diagnostics Incorporated
17.3.13.1. Company Overview
17.3.13.2. Financial Overview
17.3.13.3. Product Portfolio
17.3.13.4. Business Strategies
17.3.13.5. Recent Developments
17.3.14. Natera Inc.
17.3.14.1. Company Overview
17.3.14.2. Financial Overview
17.3.14.3. Product Portfolio
17.3.14.4. Business Strategies
17.3.14.5. Recent Developments
List of Tables
Table 01: Global Carrier Screening Market Value (US$ Bn) Forecast, By Type, 2020-2035
Table 02: Global Carrier Screening Market Value (US$ Bn) Forecast, By Sample Type, 2020-2035
Table 03: Global Carrier Screening Market Value (US$ Bn) Forecast, By Technique, 2020-2035
Table 04: Global Carrier Screening Market Value (US$ Bn) Forecast, By Application, 2020-2035
Table 05: Global Carrier Screening Market Value (US$ Bn) Forecast, By End-user, 2020-2035
Table 06: Global Carrier Screening Market Value (US$ Bn) Forecast, By Region, 2020-2035
Table 07: North America Carrier Screening Market Value (US$ Bn) Forecast, by Country, 2020-2035
Table 08: North America Carrier Screening Market Value (US$ Bn) Forecast, By Type, 2020-2035
Table 09: North America Carrier Screening Market Value (US$ Bn) Forecast, By Sample Type, 2020-2035
Table 10: North America Carrier Screening Market Value (US$ Bn) Forecast, By Technique, 2020-2035
Table 11: North America Carrier Screening Market Value (US$ Bn) Forecast, By Application, 2020-2035
Table 12: North America Carrier Screening Market Value (US$ Bn) Forecast, By End-user, 2020-2035
Table 13: Europe Carrier Screening Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
Table 14: Europe Carrier Screening Market Value (US$ Bn) Forecast, By Type, 2020-2035
Table 15: Europe Carrier Screening Market Value (US$ Bn) Forecast, By Sample Type, 2020-2035
Table 16: Europe Carrier Screening Market Value (US$ Bn) Forecast, By Technique, 2020-2035
Table 17: Europe Carrier Screening Market Value (US$ Bn) Forecast, By Application, 2020-2035
Table 18: Europe Carrier Screening Market Value (US$ Bn) Forecast, By End-user, 2020-2035
Table 19: Asia Pacific Carrier Screening Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
Table 20: Asia Pacific Carrier Screening Market Value (US$ Bn) Forecast, By Type, 2020-2035
Table 21: Asia Pacific Carrier Screening Market Value (US$ Bn) Forecast, By Sample Type, 2020-2035
Table 22: Asia Pacific Carrier Screening Market Value (US$ Bn) Forecast, By Technique, 2020-2035
Table 23: Asia Pacific Carrier Screening Market Value (US$ Bn) Forecast, By Application, 2020-2035
Table 24: Asia Pacific Carrier Screening Market Value (US$ Bn) Forecast, By End-user, 2020-2035
Table 25: Latin America Carrier Screening Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
Table 26: Latin America Carrier Screening Market Value (US$ Bn) Forecast, By Type, 2020-2035
Table 27: Latin America Carrier Screening Market Value (US$ Bn) Forecast, By Sample Type, 2020-2035
Table 28: Latin America Carrier Screening Market Value (US$ Bn) Forecast, By Technique, 2020-2035
Table 29: Latin America Carrier Screening Market Value (US$ Bn) Forecast, By Application, 2020-2035
Table 30: Latin America Carrier Screening Market Value (US$ Bn) Forecast, By End-user, 2020-2035
Table 31: Middle East & Africa Carrier Screening Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
Table 32: Middle East and Africa Carrier Screening Market Value (US$ Bn) Forecast, By Type, 2020-2035
Table 33: Middle East and Africa Carrier Screening Market Value (US$ Bn) Forecast, By Sample Type, 2020-2035
Table 34: Middle East and Africa Carrier Screening Market Value (US$ Bn) Forecast, By Technique, 2020-2035
Table 35: Middle East and Africa Carrier Screening Market Value (US$ Bn) Forecast, By Application, 2020-2035
Table 36: Middle East and Africa Carrier Screening Market Value (US$ Bn) Forecast, By End-user, 2020-2035
List of Figures
Figure 01: Global Carrier Screening Market Value Share Analysis, By Type, 2024 and 2035
Figure 02: Global Carrier Screening Market Attractiveness Analysis, By Type, 2025-2035
Figure 03: Global Carrier Screening Market Revenue (US$ Mn), by Expanded Carrier Screening, 2020-2035
Figure 04: Global Carrier Screening Market Revenue (US$ Mn), by Targeted Disease Carrier Screening, 2020-2035
Figure 05: Global Carrier Screening Market Value Share Analysis, By Sample Type, 2024 and 2035
Figure 06: Global Carrier Screening Market Attractiveness Analysis, By Sample Type, 2025-2035
Figure 07: Global Carrier Screening Market Revenue (US$ Mn), by Blood, 2020-2035
Figure 08: Global Carrier Screening Market Revenue (US$ Mn), by Saliva, 2020-2035
Figure 09: Global Carrier Screening Market Revenue (US$ Mn), by Others, 2020-2035
Figure 10: Global Carrier Screening Market Value Share Analysis, By Technique, 2024 and 2035
Figure 11: Global Carrier Screening Market Attractiveness Analysis, By Technique, 2025-2035
Figure 12: Global Carrier Screening Market Revenue (US$ Mn), by DNA Sequencing, 2020-2035
Figure 13: Global Carrier Screening Market Revenue (US$ Mn), by Polymerase Chain Reaction, 2020-2035
Figure 14: Global Carrier Screening Market Revenue (US$ Mn), by Microarrays, 2020-2035
Figure 15: Global Carrier Screening Market Revenue (US$ Mn), by Others, 2020-2035
Figure 16: Global Carrier Screening Market Value Share Analysis, By Application, 2024 and 2035
Figure 17: Global Carrier Screening Market Attractiveness Analysis, By Application, 2025-2035
Figure 18: Global Carrier Screening Market Revenue (US$ Mn), by Cystic Fibrosis, 2020-2035
Figure 19: Global Carrier Screening Market Revenue (US$ Mn), by Tay-Sachs, 2020-2035
Figure 20: Global Carrier Screening Market Revenue (US$ Mn), by Gaucher Disease, 2020-2035
Figure 21: Global Carrier Screening Market Revenue (US$ Mn), by Sickle Cell Disease, 2020-2035
Figure 22: Global Carrier Screening Market Revenue (US$ Mn), by Others, 2020-2035
Figure 23: Global Carrier Screening Market Value Share Analysis, By End-user, 2024 and 2035
Figure 24: Global Carrier Screening Market Attractiveness Analysis, By End-user, 2025-2035
Figure 25: Global Carrier Screening Market Revenue (US$ Mn), by Hospitals & Clinics, 2020-2035
Figure 26: Global Carrier Screening Market Revenue (US$ Mn), by Reference Laboratories, 2020-2035
Figure 27: Global Carrier Screening Market Revenue (US$ Mn), by Others, 2020-2035
Figure 28: Global Carrier Screening Market Value Share Analysis, By Region, 2024 and 2035
Figure 29: Global Carrier Screening Market Attractiveness Analysis, By Region, 2025-2035
Figure 30: North America Carrier Screening Market Value (US$ Mn) Forecast, 2020-2035
Figure 31: North America Carrier Screening Market Value Share Analysis, by Country, 2024 and 2035
Figure 32: North America Carrier Screening Market Attractiveness Analysis, by Country, 2025-2035
Figure 33: North America Carrier Screening Market Value Share Analysis, By Type, 2024 and 2035
Figure 34: North America Carrier Screening Market Attractiveness Analysis, By Type, 2025-2035
Figure 35: North America Carrier Screening Market Value Share Analysis, By Sample Type, 2024 and 2035
Figure 36: North America Carrier Screening Market Attractiveness Analysis, By Sample Type, 2025-2035
Figure 37: North America Carrier Screening Market Value Share Analysis, By Technique, 2024 and 2035
Figure 38: North America Carrier Screening Market Attractiveness Analysis, By Technique, 2025-2035
Figure 39: North America Carrier Screening Market Value Share Analysis, By Application, 2024 and 2035
Figure 40: North America Carrier Screening Market Attractiveness Analysis, By Application, 2025-2035
Figure 41: North America Carrier Screening Market Value Share Analysis, By End-user, 2024 and 2035
Figure 42: North America Carrier Screening Market Attractiveness Analysis, By End-user, 2025-2035
Figure 43: Europe Carrier Screening Market Value (US$ Mn) Forecast, 2020-2035
Figure 44: Europe Carrier Screening Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 45: Europe Carrier Screening Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
Figure 46: Europe Carrier Screening Market Value Share Analysis, By Type, 2024 and 2035
Figure 47: Europe Carrier Screening Market Attractiveness Analysis, By Type, 2025-2035
Figure 48: Europe Carrier Screening Market Value Share Analysis, By Sample Type, 2024 and 2035
Figure 49: Europe Carrier Screening Market Attractiveness Analysis, By Sample Type, 2025-2035
Figure 50: Europe Carrier Screening Market Value Share Analysis, By Technique, 2024 and 2035
Figure 51: Europe Carrier Screening Market Attractiveness Analysis, By Technique, 2025-2035
Figure 52: Europe Carrier Screening Market Value Share Analysis, By Application, 2024 and 2035
Figure 53: Europe Carrier Screening Market Attractiveness Analysis, By Application, 2025-2035
Figure 54: Europe Carrier Screening Market Value Share Analysis, By End-user, 2024 and 2035
Figure 55: Europe Carrier Screening Market Attractiveness Analysis, By End-user, 2025-2035
Figure 56: Asia Pacific Carrier Screening Market Value (US$ Mn) Forecast, 2020-2035
Figure 57: Asia Pacific Carrier Screening Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
Figure 58: Asia Pacific Carrier Screening Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
Figure 59: Asia Pacific Carrier Screening Market Value Share Analysis, By Type, 2024 and 2035
Figure 60: Asia Pacific Carrier Screening Market Attractiveness Analysis, By Type, 2025-2035
Figure 61: Asia Pacific Carrier Screening Market Value Share Analysis, By Sample Type, 2024 and 2035
Figure 62: Asia Pacific Carrier Screening Market Attractiveness Analysis, By Sample Type, 2025-2035
Figure 63: Asia Pacific Carrier Screening Market Value Share Analysis, By Technique, 2024 and 2035
Figure 64: Asia Pacific Carrier Screening Market Attractiveness Analysis, By Technique, 2025-2035
Figure 65: Asia Pacific Carrier Screening Market Value Share Analysis, By Application, 2024 and 2035
Figure 66: Asia Pacific Carrier Screening Market Attractiveness Analysis, By Application, 2025-2035
Figure 67: Asia Pacific Carrier Screening Market Value Share Analysis, By End-user, 2024 and 2035
Figure 68: Asia Pacific Carrier Screening Market Attractiveness Analysis, By End-user, 2025-2035
Figure 69: Latin America Carrier Screening Market Value (US$ Mn) Forecast, 2020-2035
Figure 70: Latin America Carrier Screening Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 71: Latin America Carrier Screening Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
Figure 72: Latin America Carrier Screening Market Value Share Analysis, By Type, 2024 and 2035
Figure 73: Latin America Carrier Screening Market Attractiveness Analysis, By Type, 2025-2035
Figure 74: Latin America Carrier Screening Market Value Share Analysis, By Sample Type, 2024 and 2035
Figure 75: Latin America Carrier Screening Market Attractiveness Analysis, By Sample Type, 2025-2035
Figure 76: Latin America Carrier Screening Market Value Share Analysis, By Technique, 2024 and 2035
Figure 77: Latin America Carrier Screening Market Attractiveness Analysis, By Technique, 2025-2035
Figure 78: Latin America Carrier Screening Market Value Share Analysis, By Application, 2024 and 2035
Figure 79: Latin America Carrier Screening Market Attractiveness Analysis, By Application, 2025-2035
Figure 80: Latin America Carrier Screening Market Value Share Analysis, By End-user, 2024 and 2035
Figure 81: Latin America Carrier Screening Market Attractiveness Analysis, By End-user, 2025-2035
Figure 82: Middle East & Africa Carrier Screening Market Value (US$ Mn) Forecast, 2020-2035
Figure 83: Middle East & Africa Carrier Screening Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 84: Middle East & Africa Carrier Screening Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
Figure 85: Middle East and Africa Carrier Screening Market Value Share Analysis, By Type, 2024 and 2035
Figure 86: Middle East and Africa Carrier Screening Market Attractiveness Analysis, By Type, 2025-2035
Figure 87: Middle East and Africa Carrier Screening Market Value Share Analysis, By Sample Type, 2024 and 2035
Figure 88: Middle East and Africa Carrier Screening Market Attractiveness Analysis, By Sample Type, 2025-2035
Figure 89: Middle East and Africa Carrier Screening Market Value Share Analysis, By Technique, 2024 and 2035
Figure 90: Middle East and Africa Carrier Screening Market Attractiveness Analysis, By Technique, 2025-2035
Figure 91: Middle East and Africa Carrier Screening Market Value Share Analysis, By Application, 2024 and 2035
Figure 92: Middle East and Africa Carrier Screening Market Attractiveness Analysis, By Application, 2025-2035
Figure 93: Middle East and Africa Carrier Screening Market Value Share Analysis, By End-user, 2024 and 2035
Figure 94: Middle East and Africa Carrier Screening Market Attractiveness Analysis, By End-user, 2025-2035
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Carrier Screening Market
